Al18F-NOTA-HER2-BCH affibody PET imaging accurately map HER2 positive lesions of breast cancer

被引：0
|
作者：
Guo, Xiaoyi [1 ]
Zhou, Nina [2 ]
Liu, Jiayue [2 ]
Zhu, Hua [3 ]
Yang, Zhi [4 ]
机构：
[1] Peking Univ, Beijing, Peoples R China
[2] Peking Univ Canc Hosp, Beijing, Peoples R China
[3] Peking Univ Canc Hosp & Inst, Beijing, Peoples R China
[4] Beijing Canc Hosp & Inst, Beijing, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242516
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Targeted therapy for HER2 positive breast cancer
    Incorvati, Jason A.
    Shah, Shilpan
    Mu, Ying
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [42] Comparison of an Affibody-based Molecular Probe and 18F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT
    Guo, Xiaoyi
    Zhou, Nina
    Liu, Jiayue
    Ding, Jin
    Liu, Teti
    Song, Guohong
    Zhu, Hua
    Yang, Zhi
    RADIOLOGY, 2024, 311 (03)
  • [43] IGF2 activation of HER2 receptor in HER2 positive breast cancer cell lines
    Helu, Xousaen M.
    De Leon, Daisy D.
    CANCER RESEARCH, 2012, 72
  • [44] Delayed breast cancer surgery in HER2 positive breast cancer
    Hur, Ho
    Le, Amy
    Chang, Helena R.
    CANCER RESEARCH, 2020, 80 (04)
  • [45] Differential response of HER2 positive breast cancer based on HER2 protein expression level
    Atallah, N. M.
    Toss, M. S.
    Al Saleem, M.
    Green, A. R.
    Mongan, N. P.
    Rakha, E. A.
    JOURNAL OF PATHOLOGY, 2023, 261 : S9 - S9
  • [46] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [47] HER2-Low Breast Cancer Can Be Visualized by HER2 PET Reply
    Seban, Romain-David
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1841 - 1842
  • [48] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Kurihara, Hiroaki
    Hamada, Akinobu
    Yoshida, Masayuki
    Shimma, Schuichi
    Hashimoto, Jun
    Yonemori, Kan
    Tani, Hitomi
    Miyakita, Yasuji
    Kanayama, Yousuke
    Wada, Yasuhiro
    Kodaira, Makoto
    Yunokawa, Mayu
    Yamamoto, Harukaze
    Shimizu, Chikako
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    Tamura, Kenji
    EJNMMI RESEARCH, 2015, 5
  • [49] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Hiroaki Kurihara
    Akinobu Hamada
    Masayuki Yoshida
    Schuichi Shimma
    Jun Hashimoto
    Kan Yonemori
    Hitomi Tani
    Yasuji Miyakita
    Yousuke Kanayama
    Yasuhiro Wada
    Makoto Kodaira
    Mayu Yunokawa
    Harukaze Yamamoto
    Chikako Shimizu
    Kazuhiro Takahashi
    Yasuyoshi Watanabe
    Yasuhiro Fujiwara
    Kenji Tamura
    EJNMMI Research, 5
  • [50] Understanding the spectrum of HER2 status in breast cancer: From HER2-positive to ultra-low HER2
    Ahuja, Sana
    Khan, Adil Aziz
    Zaheer, Sufian
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 262
12345